<DOC>
	<DOCNO>NCT00683358</DOCNO>
	<brief_summary>Feasibility efficacy combine modality intervention use chemotherapeutic agent gemcitabine anti-angiogenic peptide vaccination target VRGFR1 determine case advanced/inoperable therapy-resistant pancreatic cancer patient . Gemcitabine 1,000mg/m2 BSA administer day1 , day8 , day15 , day29 , day36 , day43 , respectively . HLA-A*2402-restricted VEGFR1-derived peptide ( VEGFR1-A24-1084 ; SYGVLLWEI ) emulsify Montanide ISA51 subcutaneously inject twice weekly 8weeks ( total 16 dos ) .</brief_summary>
	<brief_title>Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination Advanced Pancreatic Cancer</brief_title>
	<detailed_description>HLA-A*2402-restricted cytotoxic T lymphocyte ( CTL ) clone obtain healthy volunteer donor peripheral blood . These CTL clone show potent cytotoxicity selectively VEGFR1-expressing target cell HLA-class I-restricted manner .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<criteria>Heterozygote homozygote HLAA*2402 allele Inoperable recurrent pancreatic cancer without prior therapy Difficult continue prior therapy due treatmentrelated toxicity ECOG performance status 02 Evaluable primary metastatic lesion RECIST criterion Clearance period prior therapy 4 week Life expectancy 3 month Laboratory value follow 2,000/μL &lt; WBC &lt; 15,000/μL Platelet count &gt; 100,000/μL AST &lt; 150IU/L ALT &lt; 150IU/L Total bilirubin &lt; 3.0mg/dl Serum creatinine &lt; 3.0mg/dl Pregnancy ( refusal inability use effective contraceptive ) Breastfeeding Active uncontrolled infection Systemic use corticosteroid immunosuppressant Uncontrollable brain metastasis and/or meningeal infiltration Unhealed external wound Possibilities complicate paralytic ileus interstitial pneumonitis Decision eligible determine principal investigator attend doctor</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>cancer</keyword>
	<keyword>pancreas</keyword>
	<keyword>advanced</keyword>
	<keyword>peptide</keyword>
	<keyword>vaccination</keyword>
	<keyword>VEGFR1</keyword>
	<keyword>HLA</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>IFA</keyword>
	<keyword>Cancer Pancreas</keyword>
	<keyword>Neoplasms , Pancreatic</keyword>
	<keyword>Pancreas Cancer</keyword>
</DOC>